| __timestamp | Dynavax Technologies Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 2819557000 |
| Thursday, January 1, 2015 | 4050000 | 4103728000 |
| Friday, January 1, 2016 | 11043000 | 4860427000 |
| Sunday, January 1, 2017 | 327000 | 5872227000 |
| Monday, January 1, 2018 | 8198000 | 6710800000 |
| Tuesday, January 1, 2019 | 35219000 | 7863400000 |
| Wednesday, January 1, 2020 | 46551000 | 8497100000 |
| Friday, January 1, 2021 | 439442000 | 16071700000 |
| Saturday, January 1, 2022 | 722683000 | 12172900000 |
| Sunday, January 1, 2023 | 232284000 | 13117200000 |
| Monday, January 1, 2024 | 14202000000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Dynavax Technologies Corporation have showcased contrasting revenue trajectories. Regeneron, a leader in the biotech industry, has seen its revenue soar by over 360% from 2014 to 2023, peaking at approximately $13.1 billion in 2023. This growth underscores Regeneron's robust pipeline and strategic market positioning.
Conversely, Dynavax Technologies, while experiencing a significant revenue surge of over 2000% from 2014 to 2021, faced a decline in 2023, with revenues dropping to around $232 million. This fluctuation highlights the challenges smaller biotech firms face in maintaining consistent growth amidst market volatility. As the biotech landscape evolves, these revenue trends offer valuable insights into the strategic maneuvers of industry players.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Telix Pharmaceuticals Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Who Generates More Revenue? ADMA Biologics, Inc. or Dynavax Technologies Corporation
Who Generates More Revenue? Geron Corporation or Dynavax Technologies Corporation
Who Generates More Revenue? Dynavax Technologies Corporation or Travere Therapeutics, Inc.